Search results :

17-hydroxyprogesterone

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: G03DA03

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1
Injection site pain 32.7% - 34.8% x
Premature labour 13.8% - 16% x
Injection site swelling 7.8% - 17.1% x
Urticaria postmarketing, 11.1% - 12.3% x
Pruritus 5.9% - 7.7% x
Pre-eclampsia 4.6% - 8.8% x
Gestational hypertension 4.6% - 8.8% x
Nausea 4.6% - 5.8% x
Gestational diabetes 4.6% - 5.6% x
Injection site pruritus 3.3% - 5.8% x
Injection site nodule 2% - 4.5% x
Oligohydramnios 1.3% - 3.6% x
Diarrhoea 0.7% - 2.3% x
Breast disorder postmarketing x
Cervical incompetence postmarketing x
Infection postmarketing x
Dizziness postmarketing x
Dyspnoea postmarketing x
Rash postmarketing x
Fatigue postmarketing x
Premature rupture of membranes postmarketing x
Body temperature increased postmarketing x
Flushing postmarketing x
Headache postmarketing x
Hypersensitivity postmarketing x
Nervous system disorder postmarketing x
Pregnancy postmarketing x
Erythema postmarketing x
Urinary tract infection postmarketing x
Vomiting postmarketing x
Injection site reaction postmarketing x
Chest discomfort postmarketing x
Warmth postmarketing x
Hot flush postmarketing x
Shortened cervix postmarketing x
Abortion spontaneous x
Complication of pregnancy x
Pulmonary embolism x
Swelling x
Premature delivery x
Stillbirth x
Injection site cellulitis x

Indications

No indications were found.

HYDROXYPROGESTERONE

Side effects:42
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label